Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Dec;54(3):778–784.

The primary immune response in patients with selective IgA deficiency.

P A De Graeff, T H The, P J van Munster, T A Out, J M Vossen, B J Zegers
PMCID: PMC1536142  PMID: 6652975

Abstract

The primary immune response in vivo of 20 patients with selective IgA deficiency was studied and compared to controls. The primary cellular immune response tested by dinitrochlorobenzene (DNCB) was decreased in many patients. The primary humoral immune response was elicited by immunization with the test immunogen Helix pomatia haemocyanin (HPH). Using a direct ELISA technique antibodies against HPH of the IgA, IgG and IgM class were measured. Two weeks after immunization no response of IgA anti-HPH was seen except in three patients who showed a low but detectable antibody level. In spite of normal or even elevated serum IgG and IgM levels there was a significantly lower response of the IgG and IgM anti-HPH antibodies at 2 weeks after immunization as compared to the controls followed by a further decline at 6 weeks. We conclude that selective IgA deficiency is often accompanied by more general disturbances in humoral and cellular immunity to newly encountered antigens.

Full text

PDF
778

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammann A. J., Hong R. Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine (Baltimore) 1971 May;50(3):223–236. [PubMed] [Google Scholar]
  2. Atwater J. S., Tomasi T. B., Jr Suppressor cells and IgA deficiency. Clin Immunol Immunopathol. 1978 Mar;9(3):379–384. doi: 10.1016/0090-1229(78)90110-1. [DOI] [PubMed] [Google Scholar]
  3. Burgio G. R., Duse M., Monafo V., Ascione A., Nespoli L. Selective IgA deficiency: clinical and immunological evaluation of 50 pediatric patients. Eur J Pediatr. 1980 Mar;133(2):101–106. doi: 10.1007/BF00441577. [DOI] [PubMed] [Google Scholar]
  4. Cassidy J. T., Oldham G., Platts-Mills T. A. Functional assessment of a B cell defect in patients with selective IgA deficiency. Clin Exp Immunol. 1979 Feb;35(2):296–305. [PMC free article] [PubMed] [Google Scholar]
  5. Conley M. E., Cooper M. D. Immature IgA B cells in IgA-deficient patients. N Engl J Med. 1981 Aug 27;305(9):495–497. doi: 10.1056/NEJM198108273050905. [DOI] [PubMed] [Google Scholar]
  6. De la Concha E. G., Subiza J. L., Fontán G., Pascual-Salcedo D., Sequí J., Bootello A. Disorders of regulatory T cells in patients with selective IgA deficiency and its relationship to associated autoimmune phenomena. Clin Exp Immunol. 1982 Aug;49(2):410–418. [PMC free article] [PubMed] [Google Scholar]
  7. Delespesse G., Gausset P., Cauchie C., Govaerts A. Cellular aspects of selective IgA deficiency. Clin Exp Immunol. 1976 May;24(2):273–279. [PMC free article] [PubMed] [Google Scholar]
  8. King M. A., Wells J. V., Nelson D. S. IgA synthesis by peripheral blood mononuclear cells from normal and selectively IgA deficient subjects. Clin Exp Immunol. 1979 Nov;38(2):306–315. [PMC free article] [PubMed] [Google Scholar]
  9. Ritchie D. G., Nickerson J. M., Fuller G. M. Two simple programs for the analysis of data from enzyme-linked immunosorbent (ELISA) assays on a programmable desk-top calculator. Anal Biochem. 1981 Jan 15;110(2):281–290. doi: 10.1016/0003-2697(81)90193-7. [DOI] [PubMed] [Google Scholar]
  10. Stallman P. J., Aalberse R. C. Estimation of basophil-bound IgE by quantitative immunofluorescence microscopy. Int Arch Allergy Appl Immunol. 1977;54(1):9–18. doi: 10.1159/000231803. [DOI] [PubMed] [Google Scholar]
  11. Waldmann T. A., Broder S., Krakauer R., Durm M., Meade B., Goldman C. Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency. Trans Assoc Am Physicians. 1976;89:215–224. [PubMed] [Google Scholar]
  12. Weits J., de Gast G. C., The T. H., Esselink M. T., Deelder A. M., Petrovic M., Mandema E. Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol. 1978 Jun;32(3):443–450. [PMC free article] [PubMed] [Google Scholar]
  13. Wu L. Y., Lawton A. R., Cooper M. D. Differentiation capacity of cultured B lymphocytes from immunodeficient patients. J Clin Invest. 1973 Dec;52(12):3180–3189. doi: 10.1172/JCI107518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Zegers B. J., Stoop J. W., Reerink-Brongers E. E., Sander P. C., Aalberse R. C., Ballieux R. E. Serum immunoglobulins in healthy children and adults. Levels of the five classes, expressed in international units per millilitre. Clin Chim Acta. 1975 Dec 15;65(3):319–329. doi: 10.1016/0009-8981(75)90257-0. [DOI] [PubMed] [Google Scholar]
  15. de Gast G. C., The T. H., Snijder J. A. The human immune response to alpha-haemocyanin of Helix pomatia. Acta Med Scand. 1973 Oct;194(4):303–309. doi: 10.1111/j.0954-6820.1973.tb19450.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES